NM_017739.4(POMGNT1):c.1867A>G (p.Met623Val) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
- Germline classification:
- Benign (1 submission)
- Last evaluated:
- Oct 25, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001789218.2
Allele description [Variation Report for NM_017739.4(POMGNT1):c.1867A>G (p.Met623Val)]
NM_017739.4(POMGNT1):c.1867A>G (p.Met623Val)
Condition(s)
- Name:
- Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
- Synonyms:
- WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMGNT1-RELATED; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3; Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3
- Identifiers:
- MONDO: MONDO:0009667; MedGen: C3151519; OMIM: 253280
Assertion and evidence details
Last Updated: Sep 29, 2024